logo
Select company
Select metric
-100.16%Operating Cash Flow Margin
VS
Market
11
Sector
38
Industry
26
History
25
$ 3.15Close
$ 2.08 - $ 6.95 52-Week Range
Ticker Information

Ticker

VVOS

Company Name

VIVOS THERAPEUTICS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

VIVOS THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VVOS - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -14.42M-100.16%$ 14.39M
3/31/2025$ -13.97M-95.51%$ 14.63M
12/31/2024$ -12.69M-84.43%$ 15.03M
9/30/2024$ -12.5M-85.72%$ 14.58M
6/30/2024$ -11.11M-79.25%$ 14.02M
3/31/2024$ -10.92M-81.74%$ 13.36M
12/31/2023$ -11.95M-86.56%$ 13.8M
9/30/2023$ -12.2M-84.11%$ 14.5M
6/30/2023$ -15.24M-98.65%$ 15.45M
3/31/2023$ -17.04M-104.97%$ 16.24M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VIVOS THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at -46.87%.
  • Over the past 5 years, VIVOS THERAPEUTICS INC's average OCF % has been -90.31%.
  • The median OCF % for VIVOS THERAPEUTICS INC during this period was -93.19%
  • VIVOS THERAPEUTICS INC reached its highest OCF % over the past 5 years at -43.47%.
  • The lowest OCF % recorded by VIVOS THERAPEUTICS INC in the same timeframe -125.75%

VIVOS THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
NMTC : NEUROONE MEDICAL TECHNOLOGIES CORP -41.32%XLO : XILIO THERAPEUTICS INC -88.85%NEPH : NEPHROS INC 11.97%ALUR : ALLURION TECHNOLOGIES INC -209.97%POCI : PRECISION OPTICS CORPORATION INC -18.58%COCH : ENVOY MEDICAL INC -6927.93%NXGL : NEXGEL INC -24.69%BCAB : BIOATLA INC -475.66%XAIR : BEYOND AIR INC -680.97%CRIS : CURIS INC -267.05%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for VIVOS THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -5.34M ] / Revenues [ $ 11.39M ]
(=) OCF % [ -46.87% ]

VVOS - Operating Cash Flow Margin, Last 5 years

-125.75%

Minimum

Sep 30, 2022

-43.47%

Maximum

Dec 31, 2020

-90.31%

Average

-93.19%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%